Cellular therapy for treatment of stress urinary incontinence

Current Stem Cell Research and Therapy

Volumn 5, Issue 1, 2010, Pages 57-62

  Stangel Wójcikiewicz, Klaudia ^a   Małgorzata, Stec ^a   Nikolavsky, Dmitriy ^b   Chancellor, Michael B ^c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

Stem cell therapy; Stress urinary incontinence; Urethra

Indexed keywords

ADIPOSE TISSUE CELL; CELL REGENERATION; CELL THERAPY; CLINICAL TRIAL; HUMAN; MUSCLE CELL; MUSCLE DEVELOPMENT; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SPHINCTER; STEM CELL TRANSPLANTATION; STRESS INCONTINENCE; URETHRA;

CELL DIFFERENTIATION; GUIDED TISSUE REGENERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE, STRIATED; MYOBLASTS; NERVE GROWTH FACTORS; STEM CELL TRANSPLANTATION; STRESS, PHYSIOLOGICAL; URINARY INCONTINENCE;

EID: 77949398253     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488810790442840     Document Type: Review

References (60)

1. Norton P, Brubaker L. Urinary incontinence in women. Lancet 2006; 367(9504): 57-67.
2. Hampel C, Wienhold D, Benken N, Eggersmann C, Thuroff JW. Prevalence and natural history of female incontinence. Eur Urol 1997; 32 Suppl 2: 3-12.
3. Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 1998; 25(4): 723-746.
4. Meyer S, Schreyer A, De Grandi P, Hohlfeld P. The effects of birth on urinary continence mechanisms and other pelvic-floor characteristics. Obstet Gynecol 1998; 92(4 Pt 1):613-8.
5. McGuire EJ, Lytton B, Pepe V, Kohorn EI. Stress Urinary Incontinence. Obstet Gynecol 1976; 47(3): 255-64.
6. Kayigil O, Iftekhar Ahmed S, Metin A. The coexistence of intrinsic sphincter deficiency with type II stress incontinence. J Urol 1999; 162(4): 1365-6.
7. Ingber MS, Goldman HB. Retropubic synthetic midurethral slings: techniques and outcomes. Curr Urol Rep 2009; 10(5): 375-83.
8. Radley SC, Chapple CR, Bryan NP, Clarke DE, Craig DA. Effect of methoxamine on maximum urethral pressure in women with genuine stress incontinence: a placebo-controlled, double-blind crossover study. Neurourol Urodyn 2001; 20(1): 43-52.
9. Herschorn S, Glazer AA. Early experience with small volume periurethral polytetrafluoroethylene for female stress urinary incontinence. J Urol 2000; 163(6): 1838-42.
10. Sakamoto K, Sharma S, Wheeler JS. Long-term subjective continence status and use of alternative treatments by women with stress urinary incontinence after collagen injection therapy. World J Urol 2007; 25(4): 431-3.
11. Maher CF, O'Reilly BA, Dwyer PL, Carey MP, Cornish A, Schluter P. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG 2005; 112(6): 797-801.
12. Chrouser KL, Fick F, Goel A, Itano NB, Sweat SD, Lightner DJ. Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup. J Urol 2004; 171(3): 1152-5.
13. Bent AE, Tutrone RT, McLennan MT, Lloyd LK, Kennelly MJ, Badlani G. Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn 2001; 20(2): 157-65.
14. Sweat SD, Lightner DJ. Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 1999; 161(1): 93-6.
15. McKinney CD, Gaffey MJ, Gillenwater JY. Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections. J Urol 1995; 153(1): 149-51.
16. Papa Petros PE. Tissue reaction to implanted foreign materials for cure of stress incontinence. Am J Obstet Gynecol 1994; 171(4): 1159.
17. Kiilholma PJ, Chancellor MB, Makinen J, Hirsch IH, Klemi PJ. Complications of Teflon injection for stress urinary incontinence. Neurourol Urodyn 1993; 12(2): 131-7.
18. Lee JY, Cannon TW, Pruchnic R, Fraser MO, Huard J, Chancellor MB. The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14(1): 31-37; discussion 37.
19. Edwards RG. A burgeoning science of embryological genetics demands a modern ethics. Reprod Biomed Online 2007; 15 (Suppl) 1: 34-40.
20. DeLancey JO. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol 1994; 170(6): 1713-1720; discussion 1720-13.
21. Schroder HD, Reske-Nielsen E. Fiber types in the striated urethral and anal sphincters. Acta Neuropathol (Berl) 1983; 60(3-4): 278-82.
22. de Groat WC. Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol 2006; 147 (Suppl 2):S25-40.
23. Chancellor MB, Perkin H, Yoshimura N. Recent advances in the neurophysiology of stress urinary incontinence. Scand J Urol Nephrol 2005; 39(1): 21-4.
24. Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 1995; 274(2): 1014-24.
25. Kaiho Y, Kamo I, Chancellor MB, Arai Y, de Groat WC, Yoshimura N. Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol 2007; 292(2): F639-646.
26. Kamo I, Kaiho Y, Canon TW, et al. Functional analysis of active urethral closure mechanisms under sneeze induced stress condition in a rat model of birth trauma. J Urol 2006; 176(6 Pt 1): 2711-5.
27. de Groat WC. Anatomy of the central neural pathways controlling the lower urinary tract. Eur Urol 1998; 34 (Suppl 1): 2-5.
28. Kamo I, Cannon TW, Conway DA, et al. The role of bladder-to-urethral reflexes in urinary continence mechanisms in rats. Am J Physiol Renal Physiol 2004; 287(3): F434-441.
29. Kim Dk, Jankowski R, Pruchnic R, et al. In vitro and in vivo effect of lidocaine on rat muscle-derived cells for treatment of stress urinary incontinence. Urology 2009; 73(2): 437-41.
30. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411): 143-7.
31. Dezawa M, Ishikawa H, Itokazu Y, et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005; 309(5732): 314-7.
32. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998; 142(5):1257-67.
33. Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells. Gene Ther 2002; 9(10): 642-7.
34. Oshima H, Payne TR, Urish KL, et al. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 2005; 12(6):1130-41.
35. Lee JY, Qu-Petersen Z, Cao B, et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000; 150(5):1085-100.
36. Qu-Petersen Z, Deasy B, Jankowski R, et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002; 157(5): 851-64.
37. Yokoyama T, Yoshimura N, Dhir R, et al. Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol 2001; 165(1): 271-6.
38. Kwon D, Kim Y, Pruchnic R, et al. Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology 2006; 68(2): 449-54.
39. Chancellor MB, Yokoyama T, Tirney S, et al. Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourol Urodyn 2000; 19(3): 279-87.
40. Yokoyama T, Pruchnic R, Lee JY, et al. Autologous primary muscle-derived cells transfer into the lower urinary tract. Tissue Eng 2001; 7(4): 395-404.
41. Cannon TW, Lee JY, Somogyi G, et al. Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology 2003; 62(5): 958-63.
42. Chermansky CJ, Tarin T, Kwon DD, et al. Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology 2004; 63(4): 780-5.
43. Peroni D, Scambi I, Pasini A, et al. Stem molecular signature of adipose-derived stromal cells. Exp Cell Res 2008; 314(3): 603-15. Epub 2007 Oct 17.
44. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7(2): 211-28.
45. Rodriguez LV, Alfonso Z, Zhang R, Leung J, Wu B, Ignarro LJ. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci USA 2006; 103(32): 12167-72.
46. Jack GS, Almeida FG, Zhang R, Alfonso ZC, Zuk PA, Rodriguez LV. Processed lipoaspirate cells for tissue engineering of the lower urinary tract: implications for the treatment of stress urinary incontinence and bladder reconstruction. J Urol 2005; 174(5): 2041-45.
47. Zeng X, Jack GS, Zhang R. Treatment of SUI using adipose derived stem cells: Restoration of urethral function. J Urol 2006; 175:291 [abstract].
48. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004; 51:1-28.
49. Vogel G. Can old cells learn new tricks? Science 2000; 287:1418-19
50. Alison MR, Poulsom R, Forbes S, Wright NA. An introduction to stem cells. J Pathol 2002; 197(4): 419-23.
51. Kleinert S, Horton R. Retraction - autologous myoblasts and fibroblasts versus collagen [corrected] for treatment of stress urinary incontinence in women: a [corrected] randomised controlled trial. Lancet 2008; 372(9641): 789-90
52. Carr LK, Steele D, Steele S, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 881-3.
53. Nilsson CG, Kuuva N, Falconer C, Rezapour M, Ulmsten U. Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12 (Suppl 2): S5-8.
54. Ward KL, Hilton P. A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. Am J Obstet Gynecol 2004; 190(2): 324-31.
55. Nilsson CG, Palva K, Rezapour M, Falconer C. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19: 1043-7.
56. Hoshi A, Tamaki T, Tono K, et al. Reconstruction of radical prostatectomy-induced urethral damage using skeletal muscle-derived multipotent stem cells. Transplantation 2008; 85(11): 1617-24.
57. Kajbafzadeh AM, Elmi A, Payabvash S, et al. Transurethral myoblast injection for treatment of urinary incontinence in children with classic bladder extrophy. J Urol 2008; 180 (3): 1098-105
58. Kang SB, Lee HN, Lee JY, Park JS, Lee HS, Lee JY. Sphincter contractility after muscle-derived stem cells autograft into the cryo-injured anal sphincters of rats. Dis Colon Rectum 2008; 51(9): 1367-73.
59. Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adiposederived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009; 52(1): 79-86
60. Jack GS, Zhang R, Lee M, Xu Y, Wu BM, Rodríguez LV. Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials 2009; 30(19): 3259-70.